Horizon Pharma: Phase 3 Trial Did Not Meet Primary, Secondary Endpoints By: TalkMarkets December 08, 2016 at 08:53 AM EST Results "not what we hoped," says CEO. Read More >> Related Stocks: Horizon Therapeutics